Raveron versus placebo in the conservative treatment of benign prostatic hyperplasia (BPH)

K Bircan1, H A Ozen, A Ergen

  • 1Department of Urology, Faculty of Medicine, Hacettepe University, Ankara, Turkey.

Related Concept Videos